membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
17-06-24 15:50
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
18/11/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.88 | 6.15 | -22.13% | -66 | 9 | |
12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 2.02 | -47.27% | -142 | 7 | |
11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 2.02 | -47.68% | -143 | 4 | |
10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 2.02 | -40.57% | -122 | 7 | |
09/09/20 | INNATE PHARMA | Achat | 300 E | 3.68 | 2.02 | -45.26% | -136 | 5 | |
25/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.80 | 6.15 | 5.83% | 17 | 8 | |
13/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 6.60 | 6.15 | -7.01% | -21 | 6 | |
13/05/20 | ADVICENNE | Achat | 300 E | 7.72 | 1.88 | -75.77% | -227 | 4 | |
13/05/20 | ADVICENNE | Achat | 300 E | 7.72 | 1.88 | -75.77% | -227 | 4 | |
30/04/20 | ADVICENNE | Achat | 300 E | 8.82 | 1.88 | -78.81% | -236 | 6 | |
24/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.02 | 6.15 | 22.29% | 67 | 7 | |
23/04/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 2.02 | -68.22% | -205 | 7 | |
21/04/20 | INNATE PHARMA | Achat | 300 E | 6.39 | 2.02 | -68.52% | -206 | 7 | |
20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.38 | 6.15 | 40.17% | 121 | 6 | |
15/04/20 | ESKER | Achat | 300 E | 98.00 | 178.00 | 81.35% | 244 | 8 | |
08/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.33 | 6.15 | 41.79% | 125 | 9 | |
01/04/20 | ESKER | Achat | 300 E | 89.50 | 178.00 | 98.58% | 296 | 22 | |
01/04/20 | ADVICENNE | Achat | 300 E | 7.30 | 1.88 | -74.37% | -223 | 22 | |
11/02/20 | INNATE PHARMA | Achat | 300 E | 6.95 | 2.02 | -71.06% | -213 | 21 | |
30/01/20 | ADVICENNE | Achat | 300 E | 10.00 | 1.88 | -81.32% | -244 | 22 | |
27/01/20 | ADVICENNE | Achat | 300 E | 9.60 | 1.88 | -80.54% | -242 | 23 | |
21/01/20 | YMAGIS | Achat | 300 E | 1.94 | 0.80 | -58.90% | -177 | 25 | |
Enregistrements 51 à 74 sur 74 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
29/03/18 | THERADIAG | Achat | 600 E | 2.30 | 1.75 | -24.09% | -145 | 9 | |
07/03/18 | BASTIDE LE CONFORT | Achat | 600 E | 44.70 | 46.50 | 3.82% | 23 | 5 | |
07/03/18 | BASTIDE LE CONFORT | Achat | 600 E | 46.40 | 46.50 | 0.02% | 0 | 14 | |
27/02/18 | OSE IMMUNOTHERAPEUTICS | Achat | 600 E | 4.14 | 3.95 | -4.78% | -29 | 10 | |
08/02/18 | SOCIETE GENERALE | Achat | 600 E | 46.01 | 45.99 | -0.24% | -1 | 4 | |
06/02/18 | MAUNA KEA TECHNOLOGIES | Achat | 600 E | 5.19 | 3.02 | -41.97% | -252 | 6 | |
06/02/18 | MAUNA KEA TECHNOLOGIES | Achat | 600 E | 5.08 | 3.02 | -40.71% | -244 | 4 | |
31/01/18 | BASTIDE LE CONFORT | Achat | 600 E | 44.90 | 52.50 | 16.71% | 100 | 11 | |
25/01/18 | ABIONYX PHARMA | Achat | 600 E | 2.07 | 2.70 | 30.20% | 181 | 9 | |
25/01/18 | ABIONYX PHARMA | Achat | 600 E | 2.34 | 2.62 | 11.75% | 71 | 7 | |
23/01/18 | GENOMIC VISION | Achat | 600 E | 3.46 | 3.19 | -8.00% | -48 | 7 | |
17/01/18 | RIBER | Achat | 600 E | 2.97 | 4.08 | 37.14% | 223 | 11 | |
04/01/18 | INNATE PHARMA | Achat | 1 000 E | 4.97 | 5.10 | 2.41% | 24 | 9 | |
08/12/17 | RIBER | Achat | 600 E | 3.52 | 3.59 | 1.79% | 11 | 6 | |
07/11/17 | ROCTOOL SA | Achat | 600 E | 6.91 | 8.92 | 28.86% | 173 | 6 | |
03/11/17 | RIBER | Achat | 600 E | 3.00 | 4.06 | 35.10% | 211 | 7 | |
30/10/17 | RIBER | Achat | 300 E | 3.19 | 3.68 | 15.15% | 45 | 11 | |
25/10/17 | RIBER | Achat | 300 E | 3.15 | 3.69 | 16.93% | 51 | 4 | |
25/10/17 | RIBER | Achat | 300 E | 3.06 | 3.55 | 15.80% | 47 | 4 | |
25/10/17 | RIBER | Achat | 300 E | 3.10 | 3.54 | 13.98% | 42 | 4 | |
23/10/17 | RIBER | Achat | 600 E | 2.95 | 3.20 | 8.27% | 50 | 6 | |
19/10/17 | RIBER | Achat | 600 E | 2.55 | 2.65 | 3.72% | 22 | 7 | |
16/10/17 | BASTIDE LE CONFORT | Achat | 2 000 E | 43.75 | 44.90 | 2.43% | 49 | 14 | |
Enregistrements 1001 à 1014 sur 1014 |